// App-Quantinova.ai

: Prasugrel-based de-escalation vs. conventional therapy after percutaneous coronary intervention in ACS patients according to the renal function

Researchers

Presenter

  • H S Kim

Principal Investigators

  • J Kang

  • J P Yun

  • K W Park

  • D Hwang

  • J K Han

  • H M Yang

  • H J Kang

  • B K Koo

Medical Centers

  • Seoul National University Hospital, Seoul, Korea (Republic of)

Locations

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Ischemic stroke

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Prasugrel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved